Kasahara Noriyuki 4
4 · 4D Molecular Therapeutics, Inc. · Filed Sep 27, 2022
Insider Transaction Report
Form 4
Kasahara Noriyuki
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-09-23+45,000→ 45,000 totalExercise: $8.06Exp: 2032-09-22→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable with respect to 1/3 of the total shares on September 23, 2023 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on September 23, 2025. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan).